A06386 Summary:

BILL NO    A06386 

SAME AS    No same as 

SPONSOR    Rivera N (MS)

COSPNSR    Crespo, Aubry, Cook, Arroyo, McEneny, Englebright, Rivera P, Miller
           M, Castro, Stevenson, Ramos, Jaffee, Roberts, Jacobs, Weprin,
           Robinson, Scarborough

MLTSPNSR   Camara, Duprey, Finch, Linares, Maisel, McDonough, Montesano, Moya,
           Ortiz, Raia, Rivera J, Rodriguez, Saladino, Schimel

Add S6811-c, Ed L

Requires the drug Leuprolide acetate, to be labeled with a warning of the
possible side effects thereof.
Go to top

A06386 Actions:

BILL NO    A06386 

03/16/2011 referred to consumer affairs and protection
05/03/2011 reference changed to higher education
01/04/2012 referred to higher education
Go to top

A06386 Votes:

There are no votes for this bill in this legislative session.
Go to top

A06386 Text:

                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________

                                         6386

                              2011-2012 Regular Sessions

                                 I N  A S S E M B L Y

                                    March 16, 2011
                                      ___________

       Introduced  by M. of A. N. RIVERA, CRESPO, AUBRY, COOK, ARROYO, McENENY,
         ENGLEBRIGHT, P. RIVERA, M. MILLER, CASTRO, STEVENSON,  RAMOS,  JAFFEE,
         ROBERTS  --  Multi-Sponsored  by  -- M. of A. CAMARA, DUPREY, LINARES,
         MAISEL, McDONOUGH, MONTESANO, MOYA, ORTIZ, RAIA, J. RIVERA, RODRIGUEZ,
         TOWNS -- read once and referred to the Committee on  Consumer  Affairs
         and Protection

       AN  ACT  to  amend  the  education  law,  in relation to the labeling of
         Leuprolide acetate

         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:

    1    Section 1. The education law is amended by adding a new section 6811-c
    2  to read as follows:
    3    S 6811-C. LEUPROLIDE ACETATE. NO PHARMACIST SHALL DISPENSE OR SELL THE
    4  DRUG  LEUPROLIDE  ACETATE,  ALSO  KNOWN  AND  MARKETED AS LUPRON, LUPRON
    5  DEPOT, LUPRON  DEPOT-PED,  VIADUR  AND  ELIQARD,  UNLESS  THE  CONTAINER
    6  CONTAINING  SUCH  DRUG  PROVIDED  TO  THE  CONSUMER  IS LABELED WITH THE
    7  FOLLOWING WARNING:
    8    "CAUTION: THIS DRUG COULD CAUSE ADVERSE REACTIONS INCLUDING,  BUT  NOT
    9  LIMITED TO, HEART ATTACKS, DIABETES, CONVULSIONS, EXCESSIVE BLEEDING AND
   10  COULD LEAD TO DEATH."
   11    S  2. This act shall take effect on the first of January next succeed-
   12  ing the date on which it shall have become a law.




        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD08549-01-1
Go to top
Page display time = 0.108 sec